Literature DB >> 19026499

Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.

Sébastien Schmerber1, Georges Dumas, Nils Morel, Karim Chahine, Alexandre Karkas.   

Abstract

OBJECTIVE: To compare the efficiency of vestibular neurectomy (VN) and chemical labyrinthectomy (CL) in the treatment of Menière's disease's disabling vertigo, and to assess their subsequent effects on hearing.
METHODS: This is a retrospective study of 58 VN procedures and 35 CL procedures. Treatment results were assessed by caloric testing and pure-tone audiometry performed before and after treatment. Subjective success was defined by the number of recurrent attacks of vertigo and by the AAO-HNS vertigo scale.
RESULTS: Caloric testing revealed strong vestibular hyporeflexia in 91.0% of VN cases and 86.0% of CL cases. Vertigo recurred in 7.0% of cases in the VN group and in 11.4% of cases in the CL group. Mean pure-tone auditory thresholds increased from 45.00dB HL to 50.84dB HL (p=0.19) in the VN group and from 69.11dB HL to 74.51dB HL (p=0.41) in the CL group.
CONCLUSION: Vestibular neurectomy and chemical labyrinthectomy offer similar control of vertigo in patients with Menière's disease. CL is a simple, minimally invasive procedure that emerges as an effective method for treating Menière's disabling vertigo without causing significant hearing deterioration.

Entities:  

Mesh:

Year:  2008        PMID: 19026499     DOI: 10.1016/j.anl.2008.08.001

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

Review 1.  Recent surgical options for vestibular vertigo.

Authors:  Stefan Volkenstein; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

2.  Long-Term Balance Outcomes in Vestibular Ablative Surgeries.

Authors:  Fakih Cihat Eravcı; Metin Yılmaz; Ebru Şansal; Nagihan Gülhan; Recep Karamert; Hakan Tutar; Mehmet Birol Uğur
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.